Global Clinical Trial Outsourcing Market 2022-2028

Outsourcing is an important means for clinical trial sponsors to bring in outside expertise, from full-service clinical research organisations to smaller functional service providers. According to latest analysis by Publisher, the global clinical trial outsourcing market is poised to grow by USD 17 billion during 2022-2028, progressing at a CAGR of 6.1% during the forecast period.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global clinical trial outsourcing market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the clinical trial outsourcing industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the phase, application, organization size, and region. The global market for clinical trial outsourcing can be segmented by phase: phase I, phase III, phase III, phase IV. The phase III segment held the largest revenue share in 2021. Clinical trial outsourcing market is further segmented by application: cardiovascular diseases (CVDs), gastrointestinal diseases, infectious diseases, musculoskeletal disorders (MSD), neurological disorders, oncology, others. Among these, the oncology segment was accounted for the highest revenue generator in 2021. Based on organization size, the clinical trial outsourcing market is segmented into: large enterprises, small and medium-sized enterprises (SMEs). On the basis of region, the clinical trial outsourcing market also can be divided into: North America, Asia Pacific, Europe, Rest of the World (ROW).

By phase:
- phase I
- phase III
- phase III
- phase IV

By application:
- cardiovascular diseases (CVDs)
- gastrointestinal diseases
- infectious diseases
- musculoskeletal disorders (MSD)
- neurological disorders
- oncology
- others



By organization size:
- large enterprises
- small and medium-sized enterprises (SMEs)

By region:
- North America
- Asia Pacific
- Europe
- Rest of the World (ROW)

The report has also analysed the competitive landscape of the global clinical trial outsourcing market with some of the key players being Charles River Laboratories International, Inc., ICON plc, IQVIA Holdings, Inc., Labcorp Drug Development Inc., Medelis, Inc., Parexel International Corporation, Syneos Health, Inc., Thermo Fisher Scientific Inc., WuXi AppTec Co., Ltd., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global clinical trial outsourcing market.
- To classify and forecast the global clinical trial outsourcing market based on phase, application, organization size, region.
- To identify drivers and challenges for the global clinical trial outsourcing market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global clinical trial outsourcing market.
- To identify and analyze the profile of leading players operating in the global clinical trial outsourcing market.

Why Choose This Report
- Gain a reliable outlook of the global clinical trial outsourcing market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.